FL-WELLVII
3.1.2023 14:01:43 CET | Business Wire | Press release
Wellvii, manufacturer of connected smart devices for health and wellbeing, today announced a partnership with Care Daily, a software technology company with AI-based Caregiver services for senior care, to bring integrated solutions for aging-in-place experiences.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230103005097/en/
myWellvii Platform (Photo: Business Wire)
Patients are now, more than ever, extremely receptive to personal health management solutions. The consumerization and democratization of healthcare gained significant momentum prior to the pandemic and COVID-19 has further accelerated this trend. The partnership between Wellvii and Care Daily will let users take control of their wellbeing with self-monitoring and give them an enhanced view into their overall health.
“The core devices of the myWellvii Platform; the Wellvii MVS1, Wellvii Go wearable, and Wellvii Weight scale in conjunction with the Care Daily’s AI and IoT platform will enable a comprehensive solution for families to measure their health and wellness and improve their well-being.” Mark Khachaturian, PhD CEO of Wellvii.
“Care Daily has commercialized the most advanced AI Caregiver intelligence which, until today, has primarily captured data from ambient sensors in homes to learn lifestyle patterns, trends, and activities of daily living,” said David Moss, CEO of Care Daily. “Integrating Wellvii’s core devices with our AI Caregiver services unifies the lifestyle trends in the home with the biometric trends from the resident’s body, providing an unparalleled understanding of how this person is truly doing. Senior care solutions providers are excited about the opportunity to bring these differentiated services to market under their own brands.”
Both companies are in discussions with major providers to trial the combined technology in homes. Top use cases include senior care and chronic care management.
About Wellvii
Wellvii enables the delivery of healthcare at any address through its all in one comprehensive, clinically validated, connected device that measures 11 vital parameters from the finger, including an oscillometric blood pressure finger cuff. Wellvii also introduces a comprehensive wellness scoring system including the first at-home “stress test” using its proprietary fitness challenge. For more information about the myWellvii platform, click here.
1The Wellvii MVS is not a medical device and cannot be used for clinical applications in the USA. The Wellvii VitalDetect has CE Mark clearance as a Class IIa medical device in Europe. For more information on the Wellvii VitalDetect for Europe, click here. Wellvii has 60 patents issued (57 US, 2 UK, 1 EU).
Follow Wellvii on Twitter, LinkedIn, Instagram, and Facebook.
To directly contact Wellvii: info@wellvii.com.
About Care Daily
Care Daily is the only white-label home health AI and IoT SaaS that deeply personalizes the delivery of senior care through large brands. Care Daily is backed by the NIA, and the company’s award-winning AI Caregiver software intelligence is the first to achieve scientific validation for senior care assistive services in homes. Care Daily’s AI Caregiver personality and services are uniquely configurable by partners for maximum differentiation against other brands and solutions providers. The intelligence detects falls in real-time, uncovers hidden health problems, and brings families and professional caregivers together to care for seniors. Care Daily’s white-labeled solutions are utilized by some of the largest brands to quickly deploy and continually enhance personalized healthcare services for seniors in homes and communities. To learn more, visit www.CareDaily.ai or connect with us on LinkedIn.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230103005097/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Compass Pathways to Participate in Canaccord Genuity's 46th Annual Growth Conference on August 12, 20266.8.2026 13:00:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that management will attend the Canaccord Genuity's 46th Annual Growth Conference on August 12, 2026, and will participate in a fireside chat at 8:00am ET. Management will also participate in the Stifel Biotech Summit in Newport, Rhode Island, on August 10, 2026. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways We believe mental health patients deserve the possibility of a better future. Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care. Our initial focus is developing COMP360 psilocybin, a proprietary, investigational, synthetic psilocybin treatment under eva
Verdane Partners With Factbird to Accelerate Its Global Leadership Position in Manufacturing Intelligence6.8.2026 12:53:00 CEST | Press release
Verdane, the European specialist growth buyout investment firm, today announced a partnership and strategic majority investment in Factbird, a leading Danish IoT and recurring software company providing manufacturing intelligence solutions. The existing investors, Expedition Growth Capital and EIFO, are reinvesting significantly alongside Verdane. Factbird’s hardware-enabled software solutions help industrial businesses to improve productivity, reduce downtime and make more informed operational decisions that help manufacturers to gather, manage, analyse and act on production data to improve efficiency and reduce waste. Factbird’s customers experience increased production capacity and increased revenue leading to a very high return on investment that often lead to multi-million-dollar improvements. The company serves more than 300 customers including many global blue-chip customers and has established a global leadership position within digital manufacturing and industrial software int
Purina Named as First Publicly Announced NIQ ConnectAI Charter Client6.8.2026 12:45:00 CEST | Press release
Purina is among the first companies working with NIQ forward-deployed engineers to bring consumer intelligence into enterprise AI workflowsFive global companies have joined the ConnectAI Charter Program, with individual client announcements and case studies to follow across personal care, pet care, beauty and beverages NielsenIQ (NYSE: NIQ), a global leader in consumer intelligence, today named Purina as the first publicly announced client in its ConnectAI Charter Program. The announcement follows NIQ’s launch of the program with five global organizations across personal care, pet care, beauty and beverages, with additional client announcements and case studies expected as engagements advance. Through ConnectAI, NIQ forward-deployed engineers and data scientists are working within Purina’s technology environment to explore how NIQ consumer and market intelligence can support everyday AI-enabled workstreams and help teams access relevant insights more efficiently. "Understanding the nee
Compass Pathways Working with U.S. Department of Veterans Affairs for Investigational Study of Psilocybin6.8.2026 12:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today it is working with the U.S. Department of Verterans Affairs (VA) on a multi-site randomized controlled clinical trial. The study will evaluate the safety and efficacy of COMP360 psilocybin in the treatment of treatment-resistant depression (TRD) in veterans, including those with concurrent post-traumatic stress disorder (PTSD). The trial, titled "Psilocybin Intervention for Veterans Overcoming Treatment-Resistant Depression," or PIVOT, reflects VA’s commitment to pursuing innovative solutions for veterans who have not responded to existing treatments. Compass will donate the study drug - COMP360, a synthetic, proprietary pharmaceutical-grade formulation of psilocybin optimized for stability and purity. Compass will support the education and training of the investigators and their training team through the provision of training
Great Britain Leads Europe’s FMCG Inflation as NIQ Launches New Inflation Barometer6.8.2026 09:00:00 CEST | Press release
NIQ (NYSE: NIQ) today launches its new EU5 FMCG Inflation Barometer - a monthly tracker across five Western Europe markets – France, Great Britain, Germany, Italy and Spain – designed to help retailers, manufacturers and the media understand how inflation is evolving across Europe’s largest grocery markets and how shoppers are responding. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260806579111/en/ EU5 CPG Inflation slows to +1.1% The first edition of the Barometer reveals that while inflation across Europe’s FMCG sector remains relatively contained overall, significant differences persist between countries. Key findings include: Great Britain recorded the highest FMCG inflation across the EU5 at +2.3%1, above the European average of +1.1%. France and Italy reported the lowest inflation at -0.4% and +0.6% retrospectively, highlighting the uneven inflationary landscape across Europe's major economies. The monthly Barometer
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom